JavaScript Menu Courtesy of Milonic.com
[nucleotide sequence]     [protein sequence]     [ncbi BLAST]     [add construct]     [add ligand annotation]

HR3050   (TOM1L1)

6 targets assoicated with this target.
HR3050Achild(1-165)
HR3050Dchild(197-298)selected
HR3050Fchild(195-293)selected
HR3050Cchild(1-164)expression tested
HR3050Bchild(183-295)aggregation screening
HR3050Echild(9-150)X-Ray structure

database refs UniProt: Unknown_4585 (Unknown_4585)   |   HUGO: TOM1L1
status HSQC collected and crystal hits
properties length: 476 aa   |   mass: 53.00 kD   |   pI: 5.11   |   ext: 25900   |   organism: Homo sapiens
classes PSI-2, Biomedical: Cancer BioNet T1 (Rutgers), MEGA, Biomedical: Cancer BioNet, BioMedical, PSI-Biology
projects HCPIN    
best PDB match calculating ...
informatics Prof PHD data   |   DISOPRED2 data   |   Pxs: 0.064   |   Zn binding sites: no sites identified. CH type (data) CHDE type (data)
domain signatures48464 details   PF00790 details   1.25.40.90 details  
subsequence details   ie 100-200    
BLAST searches

Construct coverage schematic
Display constructs only from this target (HR3050).
Display constructs associated with this target (HR3050) and all other associated targets (HR3050D, HR3050F, HR3050B, HR3050C, HR3050E, HR3050A).


Domain and UniProt Features
    CATH 1.25.40.90
    SuperFamily 48464
    PFAM PF00790


NESG targets
    HR3050C
    HR3050A
    HR3050E
    HR3050B
    HR3050F
    HR3050D

HR3050

       PDB seq homology



Constructs and Most Advanced Status
   
HR3050-1-159-14.*

   
HR3050C-IDT-14.*

   
HR3050E-14.*

   
HR3050-181-295-14.*

   
HR3050B-IDT-14.*



most recent record
4 years, 1 day ago --     expression [3, 4]: HR3050-181-295-14.1-NC5b; expression [3, 4]: HR3050-181-295-14.1-NC5a

2006-03-15    target: HR3050
2009-02-26    construct: HR3050-181-295-14.1
2009-03-19    expression [ 3, 4 ] : HR3050-181-295-14.1-ss
2013-06-11    expression [ 3, 5 ] : HR3050-181-295-14.1-SeMb
2013-06-11    expression [ 3, 5 ] : HR3050-181-295-14.1-SeMa
2013-06-25    expression [ 3, 4 ] : HR3050-181-295-14.1-NC5b
2013-06-25    expression [ 3, 4 ] : HR3050-181-295-14.1-NC5a
2009-02-26    construct: HR3050-181-295-14.2
2009-03-19    expression [ 3, 4 ] : HR3050-181-295-14.2-ss
2009-02-26    construct: HR3050-1-159-14.3
2009-03-19    expression [ 5, 4 ] : HR3050-1-159-14.3-ss
2009-04-01    expression [ 5, 4 ] : HR3050-1-159-14.3-SeMa
2009-04-06    purification [16.0 mg]: HR3050-1-159-14.3-SeMa-GF
2009-04-14     aggregation screening [monomer,0 kD,0.0%]
2009-04-13     HR3050.001 @ Columbia; 1.55 ml at 11.274 mg/mL
2009-04-13     HR3050.002 @ HWI; 0.45 ml at 11.274 mg/mL
2009-04-01    expression [ 5, 4 ] : HR3050-1-159-14.3-NC5a
2009-04-09    purification [0.0 mg]: HR3050-1-159-14.3-NC5a-GF
2009-04-28    expression [ 5, 2 ] : HR3050-1-159-14.3-NC5b
2009-05-06    purification [33.8 mg]: HR3050-1-159-14.3-NC5b-Ni
2009-05-13    purification [13.8 mg]: HR3050-1-159-14.3-NC5b-GF
2009-05-18     HR3050.003 @ Rutgers; 0.035 ml at 0.878 mM
2009-06-03    HSQC [promising]: HR3050.003.600MHz.20C
2009-05-19     HR3050.004 @ Rutgers; 0.5 ml at 0.878 mM
2009-02-26    construct: HR3050-1-159-14.4
2009-03-19    expression [ 5, 4 ] : HR3050-1-159-14.4-ss


Available samples:

SeMet samples
HR3050.002 @ HWI HR3050.001 @ Columbia


NC5 samples
HR3050.004 @ Rutgers HR3050.003 @ Rutgers